Glyzia (50mg) 14 Tablets
Sitagliptin 50mg tablets for type 2 diabetes.
Glyzia (50mg) contains sitagliptin, a DPP-4 inhibitor for type 2 diabetes. The 50mg strength is for once-daily dosing. Take once daily as directed; may be taken with or without food.
Purpose
Treatment of type 2 diabetes mellitus as monotherapy or in combination with other antidiabetic agents.
Ingredients
Sitagliptin 50mg (as phosphate) per tablet.
Warnings
Contraindicated in diabetic ketoacidosis. Not for type 1 diabetes. Report severe abdominal pain.
Side Effects
Headache, nasopharyngitis, upper respiratory infection, hypoglycaemia when combined with insulin or sulphonylurea. Rare: pancreatitis. Report severe abdominal pain.
Storage Instructions
Store below 30°C in a dry place. Keep in original pack; protect from moisture.
| Brand | AGP Pharma |
| Status | Active |
Related Products
